Symmetry Partners’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-484	Closed	-$232K	–	583
2023 Q1	$232K	Sell	484 -169	-26%	-$79.1K	0.01%	507
2022 Q4	$275K	Sell	653 -243	-27%	-$98.1K	0.02%	478
2022 Q3	$374K	Sell	896 -219	-20%	-$109K	0.03%	381
2022 Q2	$552K	Hold	1,115	–	–	0.04%	291
2022 Q1	$628K	Hold	1,115	–	–	0.04%	308
2021 Q4	$842K	Hold	1,115	–	–	0.05%	251
2021 Q3	$807K	Hold	1,115	–	–	0.05%	272
2021 Q2	$718K	Sell	1,115 -131	-11%	-$79.7K	0.05%	309
2021 Q1	$712K	Sell	1,246 -4	-0.3%	-$2.37K	0.05%	287
2020 Q4	$729K	Buy	1,250 +1	+0.1%	+$570	0.06%	259
2020 Q3	$644K	Buy	1,249 +323	+35%	+$164K	0.05%	254
2020 Q2	$418K	Buy	926 +133	+17%	+$58.7K	0.05%	183
2020 Q1	$278K	Buy	793 +219	+38%	+$80.5K	0.06%	223
2019 Q4	$212K	Buy	+574	New	+$202K	0.04%	313
2019 Q3	–	Sell	-644	Closed	-$201K	–	339
2019 Q2	$201K	Hold	644	–	–	0.04%	316
2019 Q1	$197K	Hold	644	–	–	0.03%	309
2018 Q4	$150K	Buy	+644	New	+$173K	0.04%	296